nodes	percent_of_prediction	percent_of_DWPC	metapath
Procarbazine—XDH—Doxorubicin—thyroid cancer	0.443	0.601	CbGbCtD
Procarbazine—CYP1B1—Doxorubicin—thyroid cancer	0.294	0.399	CbGbCtD
Procarbazine—Ibuprofen—PPARG—thyroid cancer	0.00239	0.703	CrCbGaD
Procarbazine—Skin hyperpigmentation—Doxorubicin—thyroid cancer	0.00125	0.00482	CcSEcCtD
Procarbazine—Loss of consciousness—Vandetanib—thyroid cancer	0.00124	0.00477	CcSEcCtD
Procarbazine—Febrile neutropenia—Doxorubicin—thyroid cancer	0.00124	0.00476	CcSEcCtD
Procarbazine—Cough—Vandetanib—thyroid cancer	0.00123	0.00474	CcSEcCtD
Procarbazine—Pneumonia—Sorafenib—thyroid cancer	0.00122	0.00472	CcSEcCtD
Procarbazine—Convulsion—Vandetanib—thyroid cancer	0.00122	0.00471	CcSEcCtD
Procarbazine—Hypertension—Vandetanib—thyroid cancer	0.00122	0.00469	CcSEcCtD
Procarbazine—Optic neuritis—Doxorubicin—thyroid cancer	0.00121	0.00466	CcSEcCtD
Procarbazine—Arthralgia—Vandetanib—thyroid cancer	0.0012	0.00462	CcSEcCtD
Procarbazine—Anxiety—Vandetanib—thyroid cancer	0.0012	0.00461	CcSEcCtD
Procarbazine—Neuropathy peripheral—Sorafenib—thyroid cancer	0.00119	0.0046	CcSEcCtD
Procarbazine—Stomatitis—Sorafenib—thyroid cancer	0.00119	0.00457	CcSEcCtD
Procarbazine—Jaundice—Sorafenib—thyroid cancer	0.00119	0.00457	CcSEcCtD
Procarbazine—Dry mouth—Vandetanib—thyroid cancer	0.00117	0.00452	CcSEcCtD
Procarbazine—Haematemesis—Epirubicin—thyroid cancer	0.00116	0.00446	CcSEcCtD
Procarbazine—Oedema—Vandetanib—thyroid cancer	0.00115	0.00443	CcSEcCtD
Procarbazine—Epistaxis—Sorafenib—thyroid cancer	0.00115	0.00442	CcSEcCtD
Procarbazine—Infection—Vandetanib—thyroid cancer	0.00114	0.0044	CcSEcCtD
Procarbazine—Thrombosis—Epirubicin—thyroid cancer	0.00114	0.00438	CcSEcCtD
Procarbazine—Thrombocytopenia—Vandetanib—thyroid cancer	0.00113	0.00434	CcSEcCtD
Procarbazine—Nystagmus—Epirubicin—thyroid cancer	0.00113	0.00434	CcSEcCtD
Procarbazine—Haemoglobin—Sorafenib—thyroid cancer	0.0011	0.00423	CcSEcCtD
Procarbazine—Haemorrhage—Sorafenib—thyroid cancer	0.00109	0.00421	CcSEcCtD
Procarbazine—Haemoptysis—Epirubicin—thyroid cancer	0.00109	0.00418	CcSEcCtD
Procarbazine—Haematemesis—Doxorubicin—thyroid cancer	0.00107	0.00413	CcSEcCtD
Procarbazine—Thrombosis—Doxorubicin—thyroid cancer	0.00105	0.00405	CcSEcCtD
Procarbazine—Pleural effusion—Epirubicin—thyroid cancer	0.00105	0.00404	CcSEcCtD
Procarbazine—Musculoskeletal discomfort—Vandetanib—thyroid cancer	0.00105	0.00404	CcSEcCtD
Procarbazine—Nystagmus—Doxorubicin—thyroid cancer	0.00104	0.00401	CcSEcCtD
Procarbazine—Insomnia—Vandetanib—thyroid cancer	0.00104	0.00401	CcSEcCtD
Procarbazine—Paraesthesia—Vandetanib—thyroid cancer	0.00103	0.00398	CcSEcCtD
Procarbazine—Flushing—Sorafenib—thyroid cancer	0.00101	0.00391	CcSEcCtD
Procarbazine—Ibuprofen—PTGS2—thyroid cancer	0.00101	0.297	CrCbGaD
Procarbazine—Haemoptysis—Doxorubicin—thyroid cancer	0.00101	0.00387	CcSEcCtD
Procarbazine—Decreased appetite—Vandetanib—thyroid cancer	0.001	0.00385	CcSEcCtD
Procarbazine—Fatigue—Vandetanib—thyroid cancer	0.000992	0.00382	CcSEcCtD
Procarbazine—Pain—Vandetanib—thyroid cancer	0.000984	0.00379	CcSEcCtD
Procarbazine—Constipation—Vandetanib—thyroid cancer	0.000984	0.00379	CcSEcCtD
Procarbazine—Petechiae—Epirubicin—thyroid cancer	0.000978	0.00376	CcSEcCtD
Procarbazine—Dysphonia—Epirubicin—thyroid cancer	0.000978	0.00376	CcSEcCtD
Procarbazine—Arrhythmia—Sorafenib—thyroid cancer	0.000976	0.00376	CcSEcCtD
Procarbazine—Pleural effusion—Doxorubicin—thyroid cancer	0.000972	0.00374	CcSEcCtD
Procarbazine—Alopecia—Sorafenib—thyroid cancer	0.000966	0.00372	CcSEcCtD
Procarbazine—Neoplasm malignant—Epirubicin—thyroid cancer	0.000942	0.00363	CcSEcCtD
Procarbazine—Gastrointestinal pain—Vandetanib—thyroid cancer	0.000941	0.00362	CcSEcCtD
Procarbazine—Amenorrhoea—Epirubicin—thyroid cancer	0.000915	0.00353	CcSEcCtD
Procarbazine—Body temperature increased—Vandetanib—thyroid cancer	0.00091	0.0035	CcSEcCtD
Procarbazine—Abdominal pain—Vandetanib—thyroid cancer	0.00091	0.0035	CcSEcCtD
Procarbazine—Dysphonia—Doxorubicin—thyroid cancer	0.000905	0.00348	CcSEcCtD
Procarbazine—Petechiae—Doxorubicin—thyroid cancer	0.000905	0.00348	CcSEcCtD
Procarbazine—Anaemia—Sorafenib—thyroid cancer	0.000879	0.00339	CcSEcCtD
Procarbazine—Neoplasm malignant—Doxorubicin—thyroid cancer	0.000871	0.00336	CcSEcCtD
Procarbazine—Nocturia—Epirubicin—thyroid cancer	0.000867	0.00334	CcSEcCtD
Procarbazine—Syncope—Sorafenib—thyroid cancer	0.000853	0.00329	CcSEcCtD
Procarbazine—Leukopenia—Sorafenib—thyroid cancer	0.000852	0.00328	CcSEcCtD
Procarbazine—Dysarthria—Epirubicin—thyroid cancer	0.00085	0.00327	CcSEcCtD
Procarbazine—Amenorrhoea—Doxorubicin—thyroid cancer	0.000847	0.00326	CcSEcCtD
Procarbazine—Loss of consciousness—Sorafenib—thyroid cancer	0.000836	0.00322	CcSEcCtD
Procarbazine—Cough—Sorafenib—thyroid cancer	0.00083	0.0032	CcSEcCtD
Procarbazine—Asthenia—Vandetanib—thyroid cancer	0.000826	0.00318	CcSEcCtD
Procarbazine—Hypertension—Sorafenib—thyroid cancer	0.000821	0.00316	CcSEcCtD
Procarbazine—Pruritus—Vandetanib—thyroid cancer	0.000814	0.00314	CcSEcCtD
Procarbazine—Arthralgia—Sorafenib—thyroid cancer	0.00081	0.00312	CcSEcCtD
Procarbazine—Myalgia—Sorafenib—thyroid cancer	0.00081	0.00312	CcSEcCtD
Procarbazine—Nocturia—Doxorubicin—thyroid cancer	0.000802	0.00309	CcSEcCtD
Procarbazine—Dry mouth—Sorafenib—thyroid cancer	0.000792	0.00305	CcSEcCtD
Procarbazine—Diarrhoea—Vandetanib—thyroid cancer	0.000788	0.00303	CcSEcCtD
Procarbazine—Dysarthria—Doxorubicin—thyroid cancer	0.000787	0.00303	CcSEcCtD
Procarbazine—Melaena—Epirubicin—thyroid cancer	0.000786	0.00303	CcSEcCtD
Procarbazine—Infection—Sorafenib—thyroid cancer	0.000771	0.00297	CcSEcCtD
Procarbazine—Shock—Sorafenib—thyroid cancer	0.000764	0.00294	CcSEcCtD
Procarbazine—Dizziness—Vandetanib—thyroid cancer	0.000761	0.00293	CcSEcCtD
Procarbazine—Thrombocytopenia—Sorafenib—thyroid cancer	0.00076	0.00293	CcSEcCtD
Procarbazine—Neuropathy—Epirubicin—thyroid cancer	0.000755	0.00291	CcSEcCtD
Procarbazine—Anorexia—Sorafenib—thyroid cancer	0.00074	0.00285	CcSEcCtD
Procarbazine—Coma—Epirubicin—thyroid cancer	0.000735	0.00283	CcSEcCtD
Procarbazine—Vomiting—Vandetanib—thyroid cancer	0.000732	0.00282	CcSEcCtD
Procarbazine—Melaena—Doxorubicin—thyroid cancer	0.000727	0.0028	CcSEcCtD
Procarbazine—Rash—Vandetanib—thyroid cancer	0.000726	0.00279	CcSEcCtD
Procarbazine—Dermatitis—Vandetanib—thyroid cancer	0.000725	0.00279	CcSEcCtD
Procarbazine—Headache—Vandetanib—thyroid cancer	0.000721	0.00278	CcSEcCtD
Procarbazine—Musculoskeletal discomfort—Sorafenib—thyroid cancer	0.000707	0.00272	CcSEcCtD
Procarbazine—Neuropathy—Doxorubicin—thyroid cancer	0.000699	0.00269	CcSEcCtD
Procarbazine—Nausea—Vandetanib—thyroid cancer	0.000684	0.00263	CcSEcCtD
Procarbazine—Coma—Doxorubicin—thyroid cancer	0.00068	0.00262	CcSEcCtD
Procarbazine—Decreased appetite—Sorafenib—thyroid cancer	0.000675	0.0026	CcSEcCtD
Procarbazine—Fatigue—Sorafenib—thyroid cancer	0.000669	0.00258	CcSEcCtD
Procarbazine—Hepatic function abnormal—Epirubicin—thyroid cancer	0.000668	0.00257	CcSEcCtD
Procarbazine—Photosensitivity—Epirubicin—thyroid cancer	0.000665	0.00256	CcSEcCtD
Procarbazine—Pain—Sorafenib—thyroid cancer	0.000664	0.00256	CcSEcCtD
Procarbazine—Constipation—Sorafenib—thyroid cancer	0.000664	0.00256	CcSEcCtD
Procarbazine—Vascular purpura—Epirubicin—thyroid cancer	0.000653	0.00251	CcSEcCtD
Procarbazine—Gastrointestinal pain—Sorafenib—thyroid cancer	0.000635	0.00245	CcSEcCtD
Procarbazine—Hepatic function abnormal—Doxorubicin—thyroid cancer	0.000618	0.00238	CcSEcCtD
Procarbazine—Urticaria—Sorafenib—thyroid cancer	0.000617	0.00238	CcSEcCtD
Procarbazine—Photosensitivity—Doxorubicin—thyroid cancer	0.000615	0.00237	CcSEcCtD
Procarbazine—Abdominal pain—Sorafenib—thyroid cancer	0.000614	0.00236	CcSEcCtD
Procarbazine—Body temperature increased—Sorafenib—thyroid cancer	0.000614	0.00236	CcSEcCtD
Procarbazine—Purpura—Epirubicin—thyroid cancer	0.000606	0.00233	CcSEcCtD
Procarbazine—Vascular purpura—Doxorubicin—thyroid cancer	0.000604	0.00233	CcSEcCtD
Procarbazine—Lethargy—Epirubicin—thyroid cancer	0.000596	0.00229	CcSEcCtD
Procarbazine—Diplopia—Epirubicin—thyroid cancer	0.000584	0.00225	CcSEcCtD
Procarbazine—Hypersensitivity—Sorafenib—thyroid cancer	0.000572	0.0022	CcSEcCtD
Procarbazine—Purpura—Doxorubicin—thyroid cancer	0.00056	0.00216	CcSEcCtD
Procarbazine—Asthenia—Sorafenib—thyroid cancer	0.000557	0.00215	CcSEcCtD
Procarbazine—Lethargy—Doxorubicin—thyroid cancer	0.000551	0.00212	CcSEcCtD
Procarbazine—Pruritus—Sorafenib—thyroid cancer	0.000549	0.00212	CcSEcCtD
Procarbazine—Ataxia—Epirubicin—thyroid cancer	0.000549	0.00211	CcSEcCtD
Procarbazine—Diplopia—Doxorubicin—thyroid cancer	0.00054	0.00208	CcSEcCtD
Procarbazine—Diarrhoea—Sorafenib—thyroid cancer	0.000531	0.00205	CcSEcCtD
Procarbazine—Toxic epidermal necrolysis—Epirubicin—thyroid cancer	0.000526	0.00202	CcSEcCtD
Procarbazine—Dizziness—Sorafenib—thyroid cancer	0.000513	0.00198	CcSEcCtD
Procarbazine—Ataxia—Doxorubicin—thyroid cancer	0.000508	0.00196	CcSEcCtD
Procarbazine—Dysphagia—Epirubicin—thyroid cancer	0.000505	0.00194	CcSEcCtD
Procarbazine—Eosinophilia—Epirubicin—thyroid cancer	0.0005	0.00192	CcSEcCtD
Procarbazine—Pancreatitis—Epirubicin—thyroid cancer	0.000495	0.00191	CcSEcCtD
Procarbazine—Vomiting—Sorafenib—thyroid cancer	0.000494	0.0019	CcSEcCtD
Procarbazine—Angina pectoris—Epirubicin—thyroid cancer	0.000492	0.00189	CcSEcCtD
Procarbazine—Rash—Sorafenib—thyroid cancer	0.00049	0.00189	CcSEcCtD
Procarbazine—Dermatitis—Sorafenib—thyroid cancer	0.000489	0.00188	CcSEcCtD
Procarbazine—Toxic epidermal necrolysis—Doxorubicin—thyroid cancer	0.000486	0.00187	CcSEcCtD
Procarbazine—Headache—Sorafenib—thyroid cancer	0.000486	0.00187	CcSEcCtD
Procarbazine—Pancytopenia—Epirubicin—thyroid cancer	0.000479	0.00185	CcSEcCtD
Procarbazine—Dysphagia—Doxorubicin—thyroid cancer	0.000467	0.0018	CcSEcCtD
Procarbazine—Pollakiuria—Epirubicin—thyroid cancer	0.000466	0.0018	CcSEcCtD
Procarbazine—Eosinophilia—Doxorubicin—thyroid cancer	0.000462	0.00178	CcSEcCtD
Procarbazine—Nausea—Sorafenib—thyroid cancer	0.000461	0.00178	CcSEcCtD
Procarbazine—Photosensitivity reaction—Epirubicin—thyroid cancer	0.000461	0.00177	CcSEcCtD
Procarbazine—Pancreatitis—Doxorubicin—thyroid cancer	0.000458	0.00176	CcSEcCtD
Procarbazine—Angina pectoris—Doxorubicin—thyroid cancer	0.000455	0.00175	CcSEcCtD
Procarbazine—Pneumonia—Epirubicin—thyroid cancer	0.000453	0.00174	CcSEcCtD
Procarbazine—Drowsiness—Epirubicin—thyroid cancer	0.00045	0.00173	CcSEcCtD
Procarbazine—Pancytopenia—Doxorubicin—thyroid cancer	0.000443	0.00171	CcSEcCtD
Procarbazine—Neuropathy peripheral—Epirubicin—thyroid cancer	0.000441	0.0017	CcSEcCtD
Procarbazine—Jaundice—Epirubicin—thyroid cancer	0.000439	0.00169	CcSEcCtD
Procarbazine—Stomatitis—Epirubicin—thyroid cancer	0.000439	0.00169	CcSEcCtD
Procarbazine—Sweating—Epirubicin—thyroid cancer	0.000431	0.00166	CcSEcCtD
Procarbazine—Pollakiuria—Doxorubicin—thyroid cancer	0.000431	0.00166	CcSEcCtD
Procarbazine—Haematuria—Epirubicin—thyroid cancer	0.000429	0.00165	CcSEcCtD
Procarbazine—Photosensitivity reaction—Doxorubicin—thyroid cancer	0.000426	0.00164	CcSEcCtD
Procarbazine—Epistaxis—Epirubicin—thyroid cancer	0.000424	0.00163	CcSEcCtD
Procarbazine—Pneumonia—Doxorubicin—thyroid cancer	0.000419	0.00161	CcSEcCtD
Procarbazine—Drowsiness—Doxorubicin—thyroid cancer	0.000416	0.0016	CcSEcCtD
Procarbazine—Neuropathy peripheral—Doxorubicin—thyroid cancer	0.000408	0.00157	CcSEcCtD
Procarbazine—Haemoglobin—Epirubicin—thyroid cancer	0.000406	0.00156	CcSEcCtD
Procarbazine—Jaundice—Doxorubicin—thyroid cancer	0.000406	0.00156	CcSEcCtD
Procarbazine—Stomatitis—Doxorubicin—thyroid cancer	0.000406	0.00156	CcSEcCtD
Procarbazine—Haemorrhage—Epirubicin—thyroid cancer	0.000404	0.00156	CcSEcCtD
Procarbazine—Sweating—Doxorubicin—thyroid cancer	0.000399	0.00154	CcSEcCtD
Procarbazine—Haematuria—Doxorubicin—thyroid cancer	0.000397	0.00153	CcSEcCtD
Procarbazine—Epistaxis—Doxorubicin—thyroid cancer	0.000393	0.00151	CcSEcCtD
Procarbazine—Haemoglobin—Doxorubicin—thyroid cancer	0.000376	0.00145	CcSEcCtD
Procarbazine—Flushing—Epirubicin—thyroid cancer	0.000375	0.00144	CcSEcCtD
Procarbazine—Haemorrhage—Doxorubicin—thyroid cancer	0.000374	0.00144	CcSEcCtD
Procarbazine—Chills—Epirubicin—thyroid cancer	0.000362	0.0014	CcSEcCtD
Procarbazine—Arrhythmia—Epirubicin—thyroid cancer	0.000361	0.00139	CcSEcCtD
Procarbazine—Alopecia—Epirubicin—thyroid cancer	0.000357	0.00137	CcSEcCtD
Procarbazine—Flushing—Doxorubicin—thyroid cancer	0.000347	0.00134	CcSEcCtD
Procarbazine—Tension—Epirubicin—thyroid cancer	0.000345	0.00133	CcSEcCtD
Procarbazine—Nervousness—Epirubicin—thyroid cancer	0.000341	0.00132	CcSEcCtD
Procarbazine—Chills—Doxorubicin—thyroid cancer	0.000335	0.00129	CcSEcCtD
Procarbazine—Arrhythmia—Doxorubicin—thyroid cancer	0.000334	0.00129	CcSEcCtD
Procarbazine—Alopecia—Doxorubicin—thyroid cancer	0.00033	0.00127	CcSEcCtD
Procarbazine—Anaemia—Epirubicin—thyroid cancer	0.000325	0.00125	CcSEcCtD
Procarbazine—Tension—Doxorubicin—thyroid cancer	0.000319	0.00123	CcSEcCtD
Procarbazine—Nervousness—Doxorubicin—thyroid cancer	0.000316	0.00122	CcSEcCtD
Procarbazine—Syncope—Epirubicin—thyroid cancer	0.000315	0.00121	CcSEcCtD
Procarbazine—Leukopenia—Epirubicin—thyroid cancer	0.000315	0.00121	CcSEcCtD
Procarbazine—Loss of consciousness—Epirubicin—thyroid cancer	0.000309	0.00119	CcSEcCtD
Procarbazine—Cough—Epirubicin—thyroid cancer	0.000307	0.00118	CcSEcCtD
Procarbazine—Convulsion—Epirubicin—thyroid cancer	0.000305	0.00117	CcSEcCtD
Procarbazine—Hypertension—Epirubicin—thyroid cancer	0.000304	0.00117	CcSEcCtD
Procarbazine—Anaemia—Doxorubicin—thyroid cancer	0.000301	0.00116	CcSEcCtD
Procarbazine—Arthralgia—Epirubicin—thyroid cancer	0.000299	0.00115	CcSEcCtD
Procarbazine—Myalgia—Epirubicin—thyroid cancer	0.000299	0.00115	CcSEcCtD
Procarbazine—Anxiety—Epirubicin—thyroid cancer	0.000298	0.00115	CcSEcCtD
Procarbazine—Dry mouth—Epirubicin—thyroid cancer	0.000293	0.00113	CcSEcCtD
Procarbazine—Syncope—Doxorubicin—thyroid cancer	0.000292	0.00112	CcSEcCtD
Procarbazine—Leukopenia—Doxorubicin—thyroid cancer	0.000291	0.00112	CcSEcCtD
Procarbazine—Confusional state—Epirubicin—thyroid cancer	0.000289	0.00111	CcSEcCtD
Procarbazine—Oedema—Epirubicin—thyroid cancer	0.000287	0.00111	CcSEcCtD
Procarbazine—Loss of consciousness—Doxorubicin—thyroid cancer	0.000286	0.0011	CcSEcCtD
Procarbazine—Infection—Epirubicin—thyroid cancer	0.000285	0.0011	CcSEcCtD
Procarbazine—Cough—Doxorubicin—thyroid cancer	0.000284	0.00109	CcSEcCtD
Procarbazine—Shock—Epirubicin—thyroid cancer	0.000282	0.00109	CcSEcCtD
Procarbazine—Convulsion—Doxorubicin—thyroid cancer	0.000282	0.00109	CcSEcCtD
Procarbazine—Thrombocytopenia—Epirubicin—thyroid cancer	0.000281	0.00108	CcSEcCtD
Procarbazine—Hypertension—Doxorubicin—thyroid cancer	0.000281	0.00108	CcSEcCtD
Procarbazine—Tachycardia—Epirubicin—thyroid cancer	0.00028	0.00108	CcSEcCtD
Procarbazine—Hyperhidrosis—Epirubicin—thyroid cancer	0.000277	0.00107	CcSEcCtD
Procarbazine—Arthralgia—Doxorubicin—thyroid cancer	0.000277	0.00107	CcSEcCtD
Procarbazine—Myalgia—Doxorubicin—thyroid cancer	0.000277	0.00107	CcSEcCtD
Procarbazine—Anxiety—Doxorubicin—thyroid cancer	0.000276	0.00106	CcSEcCtD
Procarbazine—Anorexia—Epirubicin—thyroid cancer	0.000274	0.00105	CcSEcCtD
Procarbazine—Dry mouth—Doxorubicin—thyroid cancer	0.000271	0.00104	CcSEcCtD
Procarbazine—Hypotension—Epirubicin—thyroid cancer	0.000268	0.00103	CcSEcCtD
Procarbazine—Confusional state—Doxorubicin—thyroid cancer	0.000268	0.00103	CcSEcCtD
Procarbazine—Oedema—Doxorubicin—thyroid cancer	0.000265	0.00102	CcSEcCtD
Procarbazine—Infection—Doxorubicin—thyroid cancer	0.000264	0.00102	CcSEcCtD
Procarbazine—Musculoskeletal discomfort—Epirubicin—thyroid cancer	0.000261	0.00101	CcSEcCtD
Procarbazine—Shock—Doxorubicin—thyroid cancer	0.000261	0.00101	CcSEcCtD
Procarbazine—Thrombocytopenia—Doxorubicin—thyroid cancer	0.00026	0.001	CcSEcCtD
Procarbazine—Insomnia—Epirubicin—thyroid cancer	0.00026	0.000999	CcSEcCtD
Procarbazine—Tachycardia—Doxorubicin—thyroid cancer	0.000259	0.000998	CcSEcCtD
Procarbazine—Paraesthesia—Epirubicin—thyroid cancer	0.000258	0.000992	CcSEcCtD
Procarbazine—Hyperhidrosis—Doxorubicin—thyroid cancer	0.000257	0.000988	CcSEcCtD
Procarbazine—Somnolence—Epirubicin—thyroid cancer	0.000255	0.000982	CcSEcCtD
Procarbazine—Anorexia—Doxorubicin—thyroid cancer	0.000253	0.000975	CcSEcCtD
Procarbazine—Decreased appetite—Epirubicin—thyroid cancer	0.000249	0.000961	CcSEcCtD
Procarbazine—Hypotension—Doxorubicin—thyroid cancer	0.000248	0.000955	CcSEcCtD
Procarbazine—Fatigue—Epirubicin—thyroid cancer	0.000247	0.000953	CcSEcCtD
Procarbazine—Pain—Epirubicin—thyroid cancer	0.000245	0.000945	CcSEcCtD
Procarbazine—Constipation—Epirubicin—thyroid cancer	0.000245	0.000945	CcSEcCtD
Procarbazine—Musculoskeletal discomfort—Doxorubicin—thyroid cancer	0.000242	0.000932	CcSEcCtD
Procarbazine—Insomnia—Doxorubicin—thyroid cancer	0.00024	0.000925	CcSEcCtD
Procarbazine—Paraesthesia—Doxorubicin—thyroid cancer	0.000238	0.000918	CcSEcCtD
Procarbazine—Feeling abnormal—Epirubicin—thyroid cancer	0.000236	0.000911	CcSEcCtD
Procarbazine—Somnolence—Doxorubicin—thyroid cancer	0.000236	0.000909	CcSEcCtD
Procarbazine—Gastrointestinal pain—Epirubicin—thyroid cancer	0.000235	0.000904	CcSEcCtD
Procarbazine—Decreased appetite—Doxorubicin—thyroid cancer	0.000231	0.000889	CcSEcCtD
Procarbazine—Fatigue—Doxorubicin—thyroid cancer	0.000229	0.000882	CcSEcCtD
Procarbazine—Urticaria—Epirubicin—thyroid cancer	0.000228	0.000878	CcSEcCtD
Procarbazine—Pain—Doxorubicin—thyroid cancer	0.000227	0.000874	CcSEcCtD
Procarbazine—Constipation—Doxorubicin—thyroid cancer	0.000227	0.000874	CcSEcCtD
Procarbazine—Abdominal pain—Epirubicin—thyroid cancer	0.000227	0.000874	CcSEcCtD
Procarbazine—Body temperature increased—Epirubicin—thyroid cancer	0.000227	0.000874	CcSEcCtD
Procarbazine—Feeling abnormal—Doxorubicin—thyroid cancer	0.000219	0.000843	CcSEcCtD
Procarbazine—Gastrointestinal pain—Doxorubicin—thyroid cancer	0.000217	0.000836	CcSEcCtD
Procarbazine—Hypersensitivity—Epirubicin—thyroid cancer	0.000211	0.000814	CcSEcCtD
Procarbazine—Urticaria—Doxorubicin—thyroid cancer	0.000211	0.000812	CcSEcCtD
Procarbazine—Abdominal pain—Doxorubicin—thyroid cancer	0.00021	0.000808	CcSEcCtD
Procarbazine—Body temperature increased—Doxorubicin—thyroid cancer	0.00021	0.000808	CcSEcCtD
Procarbazine—Asthenia—Epirubicin—thyroid cancer	0.000206	0.000793	CcSEcCtD
Procarbazine—Pruritus—Epirubicin—thyroid cancer	0.000203	0.000782	CcSEcCtD
Procarbazine—Diarrhoea—Epirubicin—thyroid cancer	0.000196	0.000756	CcSEcCtD
Procarbazine—Hypersensitivity—Doxorubicin—thyroid cancer	0.000196	0.000753	CcSEcCtD
Procarbazine—Asthenia—Doxorubicin—thyroid cancer	0.00019	0.000734	CcSEcCtD
Procarbazine—Dizziness—Epirubicin—thyroid cancer	0.00019	0.000731	CcSEcCtD
Procarbazine—Pruritus—Doxorubicin—thyroid cancer	0.000188	0.000723	CcSEcCtD
Procarbazine—Vomiting—Epirubicin—thyroid cancer	0.000182	0.000703	CcSEcCtD
Procarbazine—Diarrhoea—Doxorubicin—thyroid cancer	0.000182	0.0007	CcSEcCtD
Procarbazine—Rash—Epirubicin—thyroid cancer	0.000181	0.000697	CcSEcCtD
Procarbazine—Dermatitis—Epirubicin—thyroid cancer	0.000181	0.000696	CcSEcCtD
Procarbazine—Headache—Epirubicin—thyroid cancer	0.00018	0.000692	CcSEcCtD
Procarbazine—Dizziness—Doxorubicin—thyroid cancer	0.000176	0.000676	CcSEcCtD
Procarbazine—Nausea—Epirubicin—thyroid cancer	0.00017	0.000656	CcSEcCtD
Procarbazine—Vomiting—Doxorubicin—thyroid cancer	0.000169	0.00065	CcSEcCtD
Procarbazine—Rash—Doxorubicin—thyroid cancer	0.000167	0.000645	CcSEcCtD
Procarbazine—Dermatitis—Doxorubicin—thyroid cancer	0.000167	0.000644	CcSEcCtD
Procarbazine—Headache—Doxorubicin—thyroid cancer	0.000166	0.000641	CcSEcCtD
Procarbazine—Nausea—Doxorubicin—thyroid cancer	0.000158	0.000607	CcSEcCtD
